Stock report · Delisted · Nasdaq
Aerovate Therapeutics Inc (AVTE)
2.68USD Delisted Final close · Apr 25, 2025
AVTE no longer trades. Aerovate Therapeutics was delisted from the Nasdaq in April 2025.
All prices on this page are historical. The last trade was on April 25, 2025, at $2.68.
AVTE stock price history
Final trading statistics
- Final close
- $2.68
- Final trading day
- Apr 25, 2025
- Market cap at delisting
- $77.68M
- Shares outstanding
- 28.98M
- Final 52-week range
- $1.25 – $25.29
- Avg. volume (final 3 mo.)
- 7,417
- All-time high
- $1048.71 · Apr 2024
- All-time low
- $48.09 · Jun 2024
- Return since IPO
- -88.3%
- Beta
- 0.95
- Book value / share
- $90.62
- Price / book
- 0.03
About Aerovate Therapeutics Inc
Aerovate Therapeutics was a U.S. biopharmaceutical company focused on treating pulmonary arterial hypertension. It was incorporated in 2018 and based in Waltham, Massachusetts. Its stock was delisted from the Nasdaq in April 2025, with the last trade on April 25, 2025 at $2.68.
- Exchange (former)
- Nasdaq
- Sector
- Healthcare
- Industry
- Biotechnology
- Headquarters
- Waltham, MA
- Employees
- 4
- IPO date
- June 30, 2021
- Delisted
- April 25, 2025
- SEC CIK
- 1798749
Aerovate Therapeutics financials before the delisting
The last 5 fiscal years Aerovate Therapeutics reported as a public company, fiscal year ending December.
AVTE revenue and net income
AVTE earnings per share
AVTE annual financials
| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| FY2024 | $0.00 | −$69.6M | −$27.94 |
| FY2023 | $0.00 | −$75.5M | −$2.88 |
| FY2022 | $0.00 | −$51.5M | −$2.11 |
| FY2021 | $0.00 | −$23.0M | −$37.18 |
| FY2020 | $0.00 | −$9.0M | −$3.70 |
Net income is GAAP. EPS is adjusted (non-GAAP) EPS, as reported.
Aerovate Therapeutics stock FAQ
What happened to Aerovate Therapeutics stock?
Aerovate Therapeutics was delisted from the Nasdaq in April 2025. The final close was $2.68 on April 25, 2025.
Can I still buy AVTE stock?
No. AVTE is no longer listed on the Nasdaq or any other U.S. exchange; it was removed on April 25, 2025.
What was the last price of AVTE?
AVTE last closed at $2.68 on April 25, 2025, which valued the company at about $77.68M.
How did Aerovate Therapeutics do in its last full fiscal year?
In fiscal 2024, its last full year as a public company, Aerovate Therapeutics reported revenue of $0.00 and net income of −$69.6M.
When did Aerovate Therapeutics go public?
Aerovate Therapeutics shares started trading on June 30, 2021.
AVTE no longer trades, so there is no live quote. The information on this page is for reference only and is not investment advice; see our disclaimer.